THE 60-SECOND GUIDE
GLP-1
Foundational biology · human evidence varies.
Guide prepared November 13, 2026 · profile review dates retained

What is it?
GLP-1 is a natural gut hormone that helps link a meal to insulin release and other signals involved in glucose regulation and appetite. It is the biological pathway behind several medicines, but native GLP-1 and engineered GLP-1 receptor agonists are not the same substance or product. [1]
Potential benefits
Enhances glucose-dependent insulin secretion. Helps regulate appetite and gastric emptying. [1]
Evidence & its limits
That foundational experiment was conducted in isolated rat pancreas, not a human weight-loss trial. It establishes a mechanism rather than the clinical effects of every later medicine. Human outcomes, indications, and warnings must come from studies and labels for the individual drug. [1]
Risks & unknowns
The natural hormone is not the same product as engineered medicines. Effects and warnings vary among GLP-1 receptor agonists. [1]
Status & scope
This record concerns the native hormone. Approved GLP-1 receptor agonist medicines have separate product-specific indications and warnings; they are not interchangeable with the natural hormone. [1]
The question to ask
Does the evidence match the exact product, route, condition and outcome being discussed? Check the full record and its review dates. This summary is selective; the product label and clinical assessment contain additional warnings and contraindications.
CHECK THE RECORD
Sources & review
- Full evidence record, references and review dates
- Original truncated GLP-1 insulin-release research, 1987
- FDA Drugs@FDA database
- Mojsov, Weir and Habener: original GLP-1 experiment, 1987
Guide prepared November 13, 2026 · profile review dates retained. Condensed from the linked site evidence record. This format update is not a new clinical review of every source. Consult the full profile for its evidence-review dates and targeted updates.
Selective educational summary, not treatment or dosing advice. Existing profile review dates retained; no independent clinical review.